Clinical Outcomes in Cystic Fibrosis Patients Enrolled in an Integrated Health System Specialty Pharmacy Care Modelhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster presents an evaluation of outcomes in cystic fibrosis (CF) patients within a health system specialty pharmacy care model by comparing them to established benchmarks.
The Impact of Specialty Pharmacy on Clinician Allocationhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Modelhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncologyhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomeshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-news-round-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Shields demonstrates its unwavering commitment to specialty patient care through our latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA), and multiple sclerosis (MS).
Impact of an Integrated Health System Specialty Pharmacy on HIV Clinical Outcomeshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster highlights our collaboration with Proprium Pharmacy and how the HSSP model consistently improves HIV clinical outcomes, regardless of factors like age, gender, time on service, race/ethnicity, or insurance.…
Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacieshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster highlights the impact of an HSSP model on accessing Patient Assistance Program (PAP) funding for oral oncolytic drugs. Government-insured patients received PAP support more often with brand medications…
Clinical and Quality Outcomes of a Hypertrophic Cardiomyopathy Management Program within an Integrated Health System Specialty Pharmacy Modelhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster spotlights our collaboration with NYULangone Health and highlights how the success of an ambulatory pharmacist-led program within an HSSP in efficiently handling mavacamten therapy and REMS program requirements…
Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster highlights the positive impact of introducing ACP services into a hematology/oncology clinic, leading to successful outcomes and substantial cost savings following HSSP integration. Challenges in cost estimation stemmed…
Implementation of Ambulatory Clinical Pharmacist Type 2 Diabetes Care Services Within an Integrated Health-System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster spotlights our collaboration with NYULangone Health and highlights how the integration of ACP-let medication management services, specializing in diabetes care, into an integrated HSSP results in markedly improved…